Digital Distribution & Reach
IPT is channeled through across the PMGroup network of print and digital publications and events:
IPT Subscribers 3,598 opt-in subscribers to the magazine 3 monthly emails per issue Articles and advertorials listed with direct access from email Direct links to desktop and mobile friendly content
Other direct distribution New edition notification included on the following emails: PMPS: 8,902 subscribers ICT: 3,681 subscribers EBR: 3,763 Subscribers PharmaTimes Week In Review: 7,300 subscribers PMLiVE Week in Review: 5,200 subscribers Pharmafile : 2,874 subscribers
Advertising and Promotion
New edition adverts uploaded to:
*Google Analytics Unique Users August 2025
Social Media Distribution
X followers: @IPTmag - 938 @EBRmagazine - 947 @IntClinTrials - 2,254 @PMPSmag - 940 @pharmatimes - 57,780 @pharmafocus - 48,719 @PMLiVEcom - 15,693
Linkedin followers: Samedan Ltd - 775 Innovations in Pharmaceutical Technology - 318 European Biopharmaceutical Review - 372 - 1,041 PMGroup Worldwide Ltd - 1,000 PharmaTimes Media - 13,000 followers
Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.